Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIL0A.L Regulatory News (IL0A)

  • There is currently no data for IL0A

Stabilisation Notice

25 Nov 2020 14:22

RNS Number : 5175G
Morgan Stanley & Co. Int'l plc
25 November 2020
 

 

25 November 2020

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Permanent TSB Group Holdings p.l.c.

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 18 November 2020, Morgan Stanley entity acting as Coordinating Stabilisation Manager (contact: Matteo Benedetto; telephone: 442076773409) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

 

Issuer:

Permanent TSB Group Holdings p.l.c.

Guarantor (if any):

N/A

ISIN:

XS2258541734

Aggregate nominal amount:

EUR 125,000,000

Description:

EUR 125,000,000 Fixed Rate Reset Additional Tier 1 Perpetual Contingent Temporary Write Down Securities

Stabilisation Manager(s):

Morgan Stanley & Co. International plc

Goldman Sachs International

J&E Davy

NatWest Markets Plc

Offer price:

100%

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STABABITMTTTBMM
Date   Source Headline
8th Nov 20187:00 amRNSTrading Statement
5th Nov 20184:30 pmRNSDirectorate Change
31st Oct 20187:00 amRNSDirector Declaration
4th Oct 201810:38 amRNSDirector Declaration
3rd Oct 201811:00 amRNSDirectorate Change
30th Aug 20188:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSHalf-year Report
29th Aug 20187:00 amRNS2018 Half-Year Results Commentary
31st Jul 20182:15 pmRNSSale of Non Performing Loan Portfolio
27th Jul 20187:00 amRNSDirectorate Change
24th Jul 201811:13 amRNSDirectorate Change
24th Jul 201811:00 amRNSDirectorate Change
16th May 20185:43 pmRNSResult of AGM
16th May 20185:15 pmRNSDirectorate Change
16th May 20187:00 amRNSTrading Statement
13th Apr 20182:00 pmRNSNotice of AGM
6th Apr 20183:00 pmRNSCourt approval for cancellation of deferred shares
29th Mar 201811:34 amRNSAnnual Financial Report
14th Mar 20187:00 amRNS2017 Annual Results Commentary
14th Mar 20187:00 amRNSAnnual Financial Report
21st Dec 20177:00 amRNS2017 Supervisory Review and Evaluation Process
13th Dec 20175:40 pmRNSDirector Declaration
29th Nov 201712:00 pmRNSDirectorate Change
8th Nov 20177:00 amRNSTrading Statement
18th Aug 20173:00 pmRNSHolding(s) in Company
16th Aug 20173:00 pmRNSHolding(s) in Company
15th Aug 201711:00 amRNSHolding(s) in Company
8th Aug 20172:00 pmRNSHolding(s) in Company
27th Jul 201710:00 amRNSHalf-year Report
26th Jul 20177:00 amRNS2017 Half-Year Results Commentary
26th Jul 20177:00 amRNSHalf-year Report
8th Jun 20171:00 pmRNSHolding(s) in Company
6th Jun 20172:00 pmRNSHolding(s) in Company
1st Jun 20173:30 pmRNSHolding(s) in Company
1st Jun 20173:30 pmRNSHolding(s) in Company
10th May 20174:45 pmRNSResult of AGM
10th May 20174:45 pmRNSConfirmation of Director Appointment
10th May 20177:00 amRNSTrading Update
12th Apr 201710:00 amRNSNotice of AGM
3rd Apr 201710:00 amRNSAnnual Financial Report
31st Mar 201711:00 amRNSChairman Appointment Update/New Company Secretary
8th Mar 20177:00 amRNSAnnual Financial Report
8th Mar 20177:00 amRNSAnnual Financial Report Commentary
7th Mar 20172:00 pmRNSAppointment of Chairman
16th Feb 20172:00 pmRNSAppointment of Chief Financial Officer
10th Feb 201712:00 pmRNSHolding(s) in Company
21st Dec 20163:00 pmRNSSupervisory Review & Evaluation Process Update
13th Dec 20162:30 pmRNS2016 Supervisory Review and Evaluation Process
18th Nov 201610:00 amRNSCompletion of Asset Sale
10th Nov 20167:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.